| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |